![Dennis Podlesak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Podlesak
Président chez
ADYNXX, INC.
Fortune : 3 M $ au 30/09/2026
Profil
Dennis G.
Podlesak was the founder of Cerexa, Inc., founded in 2005, where the title held was Chief Executive Officer & Director from 2005 to 2007.
Mr. Podlesak was the founder of Calixa Therapeutics, Inc., founded in 2007, where the title held was Chief Executive Officer & Director from 2007 to 2009.
Mr. Podlesak is also the founder of Transposon Therapeutics, Inc...
Mr. Podlesak is currently Chairman at Syndax Pharmaceuticals, Inc. since 2008.
Mr. Podlesak is currently Chairman at Adynxx, Inc. Mr. Podlesak is currently Director at Domain Russia Investments Ltd. Mr. Podlesak is currently Venture Partner at Domain Associates LLC since 2020.
Mr. Podlesak is currently Partner at Domain LLC.
Former positions include President, Chief Executive Officer & Director at Peninsula Pharmaceuticals, Inc. from 2005 to 2006.
Executive Chairman at Corthera, Inc. Chairman at Tobira Therapeutics, Inc. from 2015 to 2016.
Independent Director at Avanir Pharmaceuticals, Inc. from 2005 to 2015.
Director at DOV Pharmaceutical, Inc. Director at Regado Biosciences, Inc. from 2007 to 2009.
Director at Adastra Pharmaceuticals, Inc. Director at Adynxx, Inc. (Old) Director at Kalidex Pharmaceuticals, Inc. Director at National Society to Prevent Blindness Director at RightCare Solutions, Inc. Director at Exalys Therapeutics, Inc. Vice President & Head-Eye Care Division at Allergan, Inc. from 1998 to 2002.
Senior VP & Head-North American Business Unit at Novartis AG.
Member-Executive Committee at Novartis Pharmaceuticals Corp.
Principal at GlaxoSmithKline LLC.
Education includes undergraduate and MBA degrees from Pepperdine University, an undergraduate degree from Western Illinois University conferred in 1979, and a graduate degree from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 177 333 ( 0,2 % ) | 3 M $ | 30/09/2026 |
Postes actifs de Dennis Podlesak
| Sociétés | Poste | Début |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Président | 01/12/2008 |
| ADYNXX, INC. | Président | - |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. BiotechnologyHealth Technology Develops orally administered therapies to treat neurodegenerative, autoimmune and aging-related diseases | Directeur Général | - |
Domain Russia Investments Ltd.
 Domain Russia Investments Ltd. Investment ManagersFinance Operates as a venture capital firm that invests in projects that drive health science sector | Directeur/Membre du Conseil | - |
Domain LLC
 Domain LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | - |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Consultant / Advisor | 01/01/2007 |
Anciens postes connus de Dennis Podlesak
| Sociétés | Poste | Fin |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Président | 01/11/2016 |
RightCare Solutions, Inc.
 RightCare Solutions, Inc. Packaged SoftwareTechnology Services Provides software to identify and scores patients | Directeur/Membre du Conseil | 01/12/2015 |
| AVANIR PHARMACEUTICALS INC | Directeur/Membre du Conseil | 13/01/2015 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Formation de Dennis Podlesak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Commercial Services |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for illnesses in the acute care setting | Health Technology |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical and commercial development of proprietary drugs | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Calixa Therapeutics, Inc.
 Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hospital-based anti-infective therapies | Health Technology |
Adynxx, Inc. (Old)
 Adynxx, Inc. (Old) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kalidex Pharmaceuticals, Inc.
 Kalidex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops antibiotics for the treatment of serious infections | Health Technology |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Finance |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Illinois University
 Western Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
National Society to Prevent Blindness
 National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services Provides volunteer eye health and safety organization | Commercial Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
RightCare Solutions, Inc.
RightCare Solutions, Inc. Packaged SoftwareTechnology Services Provides software to identify and scores patients | Technology Services |
Domain LLC
Domain LLC Investment ManagersFinance Provides investment advice | Finance |
Domain Russia Investments Ltd.
Domain Russia Investments Ltd. Investment ManagersFinance Operates as a venture capital firm that invests in projects that drive health science sector | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Adynxx, Inc.
 Adynxx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops and markets novel & disease-modifying products for treatment of pain and inflammation | Health Technology |
Exalys Therapeutics, Inc.
 Exalys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. BiotechnologyHealth Technology Develops orally administered therapies to treat neurodegenerative, autoimmune and aging-related diseases | Health Technology |
